MTHFR and non-Hodgkin lymphoma: A few studies that investigated the influence of MTHFR polymorphisms on HD-MTX-related toxicity in patients with NHL reported conflicting results.3,7,9 However, most of these studies included heterogeneous groups of patients, regarding the type of hematologic malignancy and treatment protocols.